Dipyridamole (Carilion Materials Management)
Welcome to the PulseAid listing for the Dipyridamole drug offered from Carilion Materials Management. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Carilion Materials Management |
NON-PROPRIETARY NAME: | Dipyridamole |
SUBSTANCE NAME: | DIPYRIDAMOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2012-02-15 |
END MARKETING DATE: | 0000-00-00 |
Dipyridamole HUMAN PRESCRIPTION DRUG Details:
Item Description | Dipyridamole from Carilion Materials Management |
LABELER NAME: | Carilion Materials Management |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2012-02-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68151-2996_b9687fa0-6189-4b5c-b459-fd3fe2cd8861 |
PRODUCT NDC: | 68151-2996 |
APPLICATION NUMBER: | NDA012836 |
Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers: